Literature DB >> 21444322

Preliminary evidence of hippocampal damage in chronic users of ecstasy.

Bjørnar den Hollander1, Marieke Schouw, Paul Groot, Henk Huisman, Matthan Caan, Frederik Barkhof, Liesbeth Reneman.   

Abstract

Various studies have shown that ecstasy (3,4-methylenedioxymethamphetamine) users display significant memory impairments, whereas their performance on other cognitive tests is generally normal. The hippocampus plays an essential role in short-term memory. There are, however, no structural human data on the effects of ecstasy on the hippocampus. The objective of this study was to investigate whether the hippocampal volume of chronic ecstasy users is reduced when compared with healthy polydrug-using controls, as an indicator of hippocampal damage. The hippocampus was manually outlined in volumetric MRI scans in 10 male ecstasy users (mean age 25.4 years) and seven healthy age- and gender-matched control subjects (21.3 years). Other than the use of ecstasy, there were no statistically significant differences between both groups in exposure to other drugs of abuse and alcohol. The ecstasy users were on average drug-free for more than 2 months and had used on average 281 tablets over the past six and a half years. The hippocampal volume in the ecstasy using group was on average 10.5% smaller than the hippocampal volume in the control group (p=0.032). These data provide preliminary evidence that ecstasy users may be prone to incurring hippocampal damage, in line with previous reports of acute hippocampal sclerosis and subsequent atrophy in chronic users of this drug.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21444322     DOI: 10.1136/jnnp.2010.228387

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  MDMA and 5-HT neurotoxicity: the empirical evidence for its adverse effects in humans - no need for translation.

Authors:  Andrew C Parrott
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

2.  Cerebellar neuronal apoptosis in heroin-addicted rats and its molecular mechanism.

Authors:  Hongwei Pu; Xuemei Wang; Jianlong Zhang; Chuang Ma; Yinxia Su; Xiujuan Li; Xiaoshan Liu; Liping Su
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

Review 3.  Targeting memory processes with drugs to prevent or cure PTSD.

Authors:  Christopher K Cain; George D Maynard; John H Kehne
Journal:  Expert Opin Investig Drugs       Date:  2012-07-27       Impact factor: 6.206

Review 4.  Neuroimaging, nutrition, and iron-related genes.

Authors:  Neda Jahanshad; Priya Rajagopalan; Paul M Thompson
Journal:  Cell Mol Life Sci       Date:  2013-07-02       Impact factor: 9.261

5.  Expression of alcoholism-relevant genes in the liver are differently correlated to different parts of the brain.

Authors:  Lishi Wang; Yue Huang; Yan Jiao; Hong Chen; Yanhong Cao; Beth Bennett; Yongjun Wang; Weikuan Gu
Journal:  Gene Expr       Date:  2013

6.  Brain damages in ketamine addicts as revealed by magnetic resonance imaging.

Authors:  Chunmei Wang; Dong Zheng; Jie Xu; Waiping Lam; D T Yew
Journal:  Front Neuroanat       Date:  2013-07-17       Impact factor: 3.856

7.  Attention deficit/hyperactivity disorders with co-existing substance use disorder is characterized by early antisocial behaviour and poor cognitive skills.

Authors:  Berit Bihlar Muld; Jussi Jokinen; Sven Bölte; Tatja Hirvikoski
Journal:  BMC Psychiatry       Date:  2013-12-13       Impact factor: 3.630

8.  Maternal vitamin C deficiency during pregnancy persistently impairs hippocampal neurogenesis in offspring of guinea pigs.

Authors:  Pernille Tveden-Nyborg; Lucile Vogt; Janne G Schjoldager; Natalie Jeannet; Stine Hasselholt; Maya D Paidi; Stephan Christen; Jens Lykkesfeldt
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

9.  Brain-derived neurotrophic factor/FK506-binding protein 5 genotype by childhood trauma interactions do not impact on hippocampal volume and cognitive performance.

Authors:  Dennis Hernaus; Ruud van Winkel; Ed Gronenschild; Petra Habets; Gunter Kenis; Machteld Marcelis; Jim van Os; Inez Myin-Germeys; Dina Collip
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

10.  Gene expression analysis indicates CB1 receptor upregulation in the hippocampus and neurotoxic effects in the frontal cortex 3 weeks after single-dose MDMA administration in Dark Agouti rats.

Authors:  Peter Petschner; Viola Tamasi; Csaba Adori; Eszter Kirilly; Romeo D Ando; Laszlo Tothfalusi; Gyorgy Bagdy
Journal:  BMC Genomics       Date:  2013-12-30       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.